Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Neumora Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- −5 vs. Q2 2025
- Shares held
- 50.7M
- −5.35M (−9.5%) vs. Q2 2025
- Total value
- $92.2M
- +$51.1M (+124.3%) vs. Q2 2025
- New holders
- 13
- 16 more added
- Sold out
- 18
- 40 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $129.2M |
| Q1 2026 | 114 | $137.2M |
| Q4 2025 | 102 | $112.7M |
| Q3 2025 | 93 | $92.2M |
| Q2 2025 | 98 | $41.1M |
| Q1 2025 | 116 | $65.2M |
| Q4 2024 | 135 | $851.6M |
| Q3 2024 | 104 | $907.0M |
| Q2 2024 | 93 | $627.4M |
| Q1 2024 | 88 | $725.4M |
| Q4 2023 | 60 | $744.8M |
| Q3 2023 | 38 | $512.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Neumora Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −55,700−100.0% | Sold out |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0 | $0 | 0.00% | −55,659−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −45,064−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −22,449−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,187−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −15,691−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −12,790−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −10,494−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −353−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |